The present invention relates to a composition for prognosis prediction of Alzheimer's disease, a kit, and a method for providing prognosis prediction information, the composition comprising a detection reagent specifically binding to any one or more genes selected from the group consisting of nitric oxide synthase 1 (Nos1), anterior pharynx defective 1 homolog B (Aph1B), ryanodine receptor 3 (Ryr3), activating transcriptional factor 6 (Atf6), inositol trisphosphate receptor (Ip3r), neprilysin (Nep), cyclin dependent kinase 5 (Cdk5) and amyloid beta-binding alcohol dehydrogenase (Abad), and can rapidly and accurately predict the prognosis of Alzheimer's disease, and determine the prognosis for a drug by comparing the expression levels before/after drug administration, thereby enabling an appropriate treatment plan according to the predicted prognosis to be determined. Therefore, the present invention can greatly contribute to a reduction in the fatality rate from Alzheimer's disease.
COMPOSITION FOR PREDICTING STAGE OF ALZHEIMER'S DISEASE, AND PREDICTION KIT USING COMPOSITION